טוען...
Tadalafil, a Phosphodiesterase-5 Inhibitor, Improves Erectile Dysfunction in Patients With Liver Cirrhosis
BACKGROUND: Erectile dysfunction(ED) is common in patients with chronic liver disease(CLD). Although it significantly worsens the quality of life, caregivers and researchers often neglect it. AIM: Evaluating the prevalence of ED in patients with CLD, associated factors, and response to therapy with...
שמור ב:
| הוצא לאור ב: | J Clin Exp Hepatol |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6637079/ https://ncbi.nlm.nih.gov/pubmed/31360023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2018.07.007 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|